Biphenyl-indanone A, a Positive Allosteric Modulator of the Metabotropic Glutamate Receptor Subtype 2, Has Antipsychotic- and Anxiolytic-Like Effects in Mice
- 11 April 2006
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 318 (1) , 173-185
- https://doi.org/10.1124/jpet.106.102046
Abstract
Previous studies indicate that agonists of the group II metabotropic glutamate receptors (mGluRs), mGluR2 and mGluR3, may provide a novel approach for the treatment of anxiety disorders and schizophrenia. However, the relative contributions of the mGluR2 and mGluR3 subtypes to the effects of the group II mGluR agonists remain unclear. In the present study, we describe an alternate synthesis and further pharmacological characterization of a recently reported positive allosteric modulator of mGluR2 termed biphenyl-indanone A (BINA). In recombinant systems, BINA produced a robust and selective potentiation of the response of mGluR2 to glutamate with no effect on the glutamate response of other mGluR subtypes. In hippocampal brain slices, BINA (1 μM) significantly potentiated the mGluR2/3 agonist-induced inhibition of excitatory synaptic transmission at the medial perforant path-dentate gyrus synapse. BINA was also efficacious in several models predictive of antipsychotic- and anxiolytic-like activity in mice. The behavioral effects of BINA were blocked by the mGluR2/3 antagonist (2S)-2-amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid (LY341495), suggesting that the in vivo effects of BINA are mediated by increased activation of mGluR2. Collectively, these results indicate that BINA is a selective mGluR2 positive allosteric modulator and provide further support for the growing evidence that selective allosteric potentiators of mGluR2 mimic many of the in vivo actions of mGluR2/3 agonists that may predict therapeutic utility of these compounds.Keywords
This publication has 33 references indexed in Scilit:
- Improved Bioavailability of the mGlu2/3 Receptor Agonist LY354740 Using a Prodrug Strategy: In Vivo Pharmacology of LY544344The Journal of Pharmacology and Experimental Therapeutics, 2006
- Biphenyl-indanones: Allosteric potentiators of the metabotropic glutamate subtype 2 receptorBioorganic & Medicinal Chemistry Letters, 2005
- Graphical contents listBioorganic & Medicinal Chemistry Letters, 2005
- Allosteric potentiators of the metabotropic glutamate receptor 2 (mGlu2). Part 3: Identification and biological activity of indanone containing mGlu2 receptor potentiatorsBioorganic & Medicinal Chemistry Letters, 2005
- Metabotropic glutamate receptors as novel targets for anxiety and stress disordersNature Reviews Drug Discovery, 2005
- Functional coupling of the human dopamine D2receptor with Gαi1, Gαi2, Gαi3and GαoG proteins: evidence for agonist regulation of G protein selectivityBritish Journal of Pharmacology, 2003
- LY354740, an mGlu2/3 Receptor Agonist as a Novel Approach to Treat Anxiety/StressStress, 2003
- Discovery of an Ectopic Activation Site on the M1Muscarinic ReceptorMolecular Pharmacology, 2002
- Stress-Induced Hyperthermia in Singly Housed MicePhysiology & Behavior, 1997
- (Acylaryloxy)acetic acid diuretics. 1. (2-Alkyl- and 2,2-dialkyl-1-oxo-5-indanyloxy)acetic acidsJournal of Medicinal Chemistry, 1977